Platelet dysfunction in intraparenchymal hemorrhage

Stroke

Volumn 40, Issue 11, 2009, Pages

  Creutzfeldt, Claire J ^a   Becker, Kyra J ^a   Longstreth Jr , W T ^a   Tirschwell, David L ^a   Weinstein, Jonathan R ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

BLEEDING; BRAIN HEMATOMA; HUMAN; INTRAPARENCHYMAL BLEEDING; LETTER; PRIORITY JOURNAL; SAMPLE SIZE; THROMBOCYTE DYSFUNCTION; THROMBOCYTE FUNCTION; TREATMENT OUTCOME;

BLOOD PLATELET DISORDERS; CEREBRAL HEMORRHAGE; HUMANS; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS;

EID: 70350528832     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.561191     Document Type: Letter

References (11)

1. Sansing LH, Messe SR, Cucchiara BL, Cohen SN, Lyden PD, Kasner SE. Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH. Neurology. 2009;72:1397-1402.
2. Broderick JP. Evidence against rapid reversal of antiplatelet medications in acute intracerebral hemorrhage. Neurology. 2009;72:1376-1377.
3. Saloheimo P, Ahonen M, Juvela S, Pyhtinen J, Savolainen ER, Hillbom M. Regular aspirin-use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death. Stroke. 2006;37:129-133.
4. Toyoda K, Okada Y, Minematsu K, Kamouchi M, Fujimoto S, Ibayashi S, Inoue T. Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage. Neurology. 2005;65:1000-1004.
5. Lacut K, Le Gal G, Seizeur R, Prat G, Mottier D, Oger E. Antiplatelet drug use preceding the onset of intracerebral hemorrhage is associated with increased mortality. Fundam Clin Pharmacol. 2007;21:327-333.
6. Creutzfeldt CJ, Weinstein JR, Longstreth WT Jr, Becker KJ, McPharlin TO, Tirschwell DL. Prior antiplatelet therapy, platelet infusion therapy, and outcome after intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2009;18:221-228.
7. Caso V, Paciaroni M, Venti M, Alberti A, Palmerini F, Milia P, Billeci AM, Silvestrelli G, Biagini S, Agnelli G. Effect of on-admission anti-platelet treatment on patients with cerebral hemorrhage. Cerebrovasc Dis. 2007;24:215-218.
8. Foerch C, Sitzer M, Steinmetz H, Neumann-Haefelin T. Pretreatment with antiplatelet agents is not independently associated with unfavorable outcome in intracerebral hemorrhage. Stroke. 2006;37:2165-2167.
9. Hanger HC, Fletcher VJ, Wilkinson TJ, Brown AJ, Frampton CM, Sainsbury R. Effect of aspirin and warfarin on early survival after intra-cerebral haemorrhage. J Neurol. 2008;255:347-352.
10. Naidech AM, Jovanovic B, Liebling S, Garg RK, Bassin SL, Bendok BR, Bernstein RA, Alberts MJ, Batjer HH. Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intrace-rebral hemorrhage. Stroke. 2009;40:2398-2401.
11. Lordkipanidze M, Pharand C, Schampaert E, Turgeon J, Palisaitis DA, Diodati JG. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J. 2007;28:1702-1708.